August 29, 2026
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
B Issued on behalf of AvaĆ Bio, Inc. USANewsGroup.com VANCOUVER, BC, March 31, 2026 /PRNewswire/ — The FDA has approved more than 40 cell and…
